Sanofi
SAN
Classificação em ações
#225
Sanofi is a global healthcare enterprise dedicated to the research,... Sanofi is a global healthcare enterprise dedicated to the research, development, manufacturing, and commercialization of therapeutic solutions across the United States, Europe, and other international markets. Its business is structured into three primary divisions: Pharmaceuticals, Vaccines, and Consumer Healthcare. The Pharmaceuticals segment delivers specialized treatments, encompassing human monoclonal antibodies and therapies for a range of conditions such as multiple sclerosis, neurological disorders, various inflammatory and immunological diseases, rare disorders, oncology, and rare blood conditions. This division also provides medications for diabetes, cardiovascular health, and a portfolio of established prescription drugs. Through its Vaccines division, Sanofi supplies crucial immunizations, including pediatric vaccines for diseases like poliomyelitis, pertussis, and Hib, alongside adult vaccines addressing influenza, booster needs, meningitis, and those required for travel or endemic regions. The Consumer Healthcare portfolio features over-the-counter remedies for common ailments such as allergies, coughs and colds, and pain relief. It also includes products for liver care, general physical and mental wellness, probiotics, digestive health, and nutritional support. Additionally, this segment offers personal care items like daily body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and powders for eczema. Sanofi maintains an active pipeline with numerous pharmaceutical products and vaccines currently undergoing various stages of development. The company has forged strategic alliances, including a collaboration with GlaxoSmithKline for the development of a recombinant Covid-19 vaccine, a research partnership with Stanford University School of Medicine aimed at advancing immunology and inflammation knowledge, and a collaboration and license option agreement with Prellis Biologics, Inc. Founded in 1973 and headquartered in Paris, France, the company operated as Sanofi-Aventis before rebranding to Sanofi in May 2011.
Preço da ação
$83.84
Valor de mercado
$100.45B
Variação (1 dia)
1.48%
Variação (1 ano)
-16.74%
País
FR
Negociar Sanofi (SAN)
Categoria
Healthcare
Margem Operacional de Sanofi (SAN)
Margem Operacional em October 2026 TTM: 20.58%
De acordo com os relatórios financeiros mais recentes e o preço das ações da Sanofi, a margem operacional atual (TTM) é 20.58%. No final de 2024, a margem operacional era 32.63%.
Histórico da Margem Operacional da Sanofi de 2001 a 2026
Margem Operacional no final de cada ano
| Ano | Margem Operacional | Alterar |
|---|---|---|
| 2026 (TTM) | 20.58% | 0.19% |
| 2025 | 20.54% | -37.05% |
| 2024 | 32.63% | 3.36% |
| 2023 | 31.57% | -3.22% |
| 2022 | 32.62% | 57.28% |
| 2021 | 20.74% | -45.09% |
| 2020 | 37.77% | 365.72% |
| 2019 | 8.11% | -38.14% |
| 2018 | 13.11% | -18.16% |
| 2017 | 16.02% | -14.88% |
| 2016 | 18.82% | 16.68% |
| 2015 | 16.13% | -14.88% |
| 2014 | 18.95% | 19.03% |
| 2013 | 15.92% | -28.19% |
| 2012 | 22.17% | 35.60% |
| 2011 | 16.35% | -12.14% |
| 2010 | 18.61% | -10.10% |
| 2009 | 20.70% | -38.90% |
| 2008 | 33.88% | 67.39% |
| 2007 | 20.24% | 4.17% |
| 2006 | 19.43% | -25.64% |
| 2005 | 26.13% | -1,593.14% |
| 2004 | -1.75% | -104.58% |
| 2003 | 38.21% | 8.89% |
| 2002 | 35.09% | 8.10% |
| 2001 | 32.46% | 0.00% |
Margem Operacional de empresas semelhantes ou concorrentes
| Empresa | Margem Operacional | Diferença na Margem Operacional | País |
|---|---|---|---|
| 49.72% | -97.58% |
US
|
|
| 25.70% | -98.75% |
US
|
|
| 29.32% | -98.58% |
US
|
|
| 16.65% | -99.19% |
US
|
|
| 31.92% | -98.45% |
CH
|
O que é a Margem Operacional de uma empresa?
A Margem Operacional é um indicador essencial para avaliar a rentabilidade de uma empresa. Margens operacionais mais altas geralmente são melhores, pois mostram que uma empresa consegue vender seus produtos ou serviços por muito mais do que o custo de produzi-los. É calculada dividindo os lucros da empresa pela sua receita.